Structure |
Chemical Name |
CAS |
MF |
![Dihydro-Simvastatin](/CAS/20200401/GIF/92083-03-9.gif) |
Dihydro-Simvastatin |
92083-03-9 |
C25H40O5 |
![Ceftriaxone Sodium impurity 3](/) |
Ceftriaxone Sodium impurity 3 |
|
|
![Sugammadex sodium Monoiodo Impurity](/) |
Sugammadex sodium Monoiodo Impurity |
|
|
![(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-methyl-4-phenylpiperidine](/CAS/20200401/GIF/CB85422885.gif) |
(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-methyl-4-phenylpiperidine |
|
C20H23NO3 |
![176760-99-9](/CAS/20200611/GIF/176760-99-9.gif) |
176760-99-9 |
176760-99-9 |
C17H13FN2O4 |
![NILOTINIB IMPURITY 17](/CAS/20210111/GIF/851137-91-2.gif) |
NILOTINIB IMPURITY 17 |
851137-91-2 |
C17H15N5O |
![DexMedetoMidine IMpurity 16](/) |
DexMedetoMidine IMpurity 16 |
|
|
![Canagliflozin Impurity 2](/) |
Canagliflozin Impurity 2 |
2952941-15-8 |
|
![Rivaroxaban Impurity 22](/) |
Rivaroxaban Impurity 22 |
|
|
![Levofloxacin Impurity 5](/CAS/20200401/GIF/2206360-62-3.gif) |
Levofloxacin Impurity 5 |
2206360-62-3 |
C13H10FNO5 |
![Ezetimibe Impurity 33](/) |
Ezetimibe Impurity 33 |
|
|
![Ezetimibe-28](/CAS/20210111/GIF/1478663-95-4.gif) |
Ezetimibe-28 |
1478663-95-4 |
C44H52F2N2O6Si |
![Vonoprazan Impurity U4](/) |
Vonoprazan Impurity U4 |
|
|
![Emtricitabine Impurity 28](/CAS/20200515/GIF/1238210-14-4.gif) |
Emtricitabine Impurity 28 |
1238210-14-4 |
C8H11N3O4S |
![Parecoxib SodiuM iMpurity 37](/) |
Parecoxib SodiuM iMpurity 37 |
|
|
![(3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine compound](/CAS/20200611/GIF/105834-21-7.gif) |
(3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine compound |
105834-21-7 |
C20H22FNO3 |
![Cabozantinib Impurity 46](/CAS/20200515/GIF/1247859-37-5.gif) |
Cabozantinib Impurity 46 |
1247859-37-5 |
C11H10FNO3 |
![Ivabradine Impurity S33172](/CAS/20200515/GIF/2247881-26-9.gif) |
Ivabradine Impurity S33172 |
2247881-26-9 |
C26H34N2O5 |
![Tenofovir Impurity 71](/) |
Tenofovir Impurity 71 |
|
|
![2-(chloromethyl)-3-methylpyridin-4-ol](/CAS/20200401/GIF/1805648-51-4.gif) |
2-(chloromethyl)-3-methylpyridin-4-ol |
1805648-51-4 |
C7H8ClNO |
![Mupirocin Calcium EP Impurity I](/CAS/20200401/GIF/CB85479591.gif) |
Mupirocin Calcium EP Impurity I |
|
C26H44CaO9 |
![Benzenepropanoic acid, α-hydroxy-β-[[(3E)-1-oxo-3-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclod](/CAS/20210111/GIF/2243233-98-7.gif) |
Benzenepropanoic acid, α-hydroxy-β-[[(3E)-1-oxo-3-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclod |
2243233-98-7 |
C46H55NO14 |
![D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-6-S-(5-methyl-1,3,4-thiadiazol-2-yl)-6-thio-, 1,1-dimethylethyl ester](/CAS/20200611/GIF/1326303-05-2.gif) |
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-6-S-(5-methyl-1,3,4-thiadiazol-2-yl)-6-thio-, 1,1-dimethylethyl ester |
1326303-05-2 |
C16H26N2O4S2 |
![L-Leucine, N-[(2S)-2-amino-1-oxo-4-phenylbutyl]-](/CAS/20200401/GIF/290298-02-1.gif) |
L-Leucine, N-[(2S)-2-amino-1-oxo-4-phenylbutyl]- |
290298-02-1 |
C16H24N2O3 |
![5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1,3-dihydro-1-hydroxy-](/CAS/20200401/GIF/2102609-59-4.gif) |
5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1,3-dihydro-1-hydroxy- |
2102609-59-4 |
C14H18N2O2 |
![L-Milnacipran Carbamoyl-beta-D-Glucuronide](/CAS/20211123/GIF/1446438-98-7.gif) |
L-Milnacipran Carbamoyl-beta-D-Glucuronide |
1446438-98-7 |
C22H30N2O9 |
![1H-Imidazole-1-carboxylic acid, (1R)-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-[[[(2R)-3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-2-[(1H-imidazol-1-ylcarbonyl)oxy]propyl][4-(3-oxo-4-morpholinyl)phenyl]amino]methyl]ethyl ester](/CAS/20200401/GIF/2097255-05-3.gif) |
1H-Imidazole-1-carboxylic acid, (1R)-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-[[[(2R)-3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-2-[(1H-imidazol-1-ylcarbonyl)oxy]propyl][4-(3-oxo-4-morpholinyl)phenyl]amino]methyl]ethyl ester |
2097255-05-3 |
C40H34N8O10 |
![Elagolix Sodium impurity5](/) |
Elagolix Sodium impurity5 |
|
|
![Tadalafil Impurity 46](/) |
Tadalafil Impurity 46 |
|
|
![(trans)-4-((2-amino-3,4-dibromobenzyl)amino)cyclohexanol](/CAS/20200401/GIF/CB85519895.gif) |
(trans)-4-((2-amino-3,4-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
![cefdinir](/) |
cefdinir |
|
|
![1H-Inden-1-amine, 2,3-dihydro-N-2-propen-1-yl-](/CAS/20200401/GIF/91639-43-9.gif) |
1H-Inden-1-amine, 2,3-dihydro-N-2-propen-1-yl- |
91639-43-9 |
C12H15N |
![(E)-8-(3,4-dimethoxystyryl)](/) |
(E)-8-(3,4-dimethoxystyryl) |
|
|
![(trans)-3-(4-((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecan-1-yl)butane-1,2,4-triol](/) |
(trans)-3-(4-((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecan-1-yl)butane-1,2,4-triol |
|
|
![Cefdinir CP Impurity B](/) |
Cefdinir CP Impurity B |
|
|
![Voriconazole Impurity 15](/CAS/20210111/GIF/321589-00-8.gif) |
Voriconazole Impurity 15 |
321589-00-8 |
C22H19F4N7O |
![Fluconazole Impurity 2](/) |
Fluconazole Impurity 2 |
|
|
![Imatinib EP Impurity D Chloride](/) |
Imatinib EP Impurity D Chloride |
|
|
![Favipiravir Impurity](/) |
Favipiravir Impurity |
|
|
![Vildagliptin Dione Impurity](/CAS/20210111/GIF/1844894-70-7.gif) |
Vildagliptin Dione Impurity |
1844894-70-7 |
C17H24N2O3 |
![Adsorption of hydrogen sulfide Adsorption of impurities in water filter material](/) |
Adsorption of hydrogen sulfide Adsorption of impurities in water filter material |
|
|
![Citalopram impurity 9/Citalopram EP Impurity C Oxalate Salt/3-Oxo Citalopram Oxalate Salt/Citalopram Related Compound C Oxalate Salt/3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate](/CAS/20210111/GIF/1440961-11-4.gif) |
Citalopram impurity 9/Citalopram EP Impurity C Oxalate Salt/3-Oxo Citalopram Oxalate Salt/Citalopram Related Compound C Oxalate Salt/3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate |
1440961-11-4 |
C22H21FN2O6 |
![1H-Pyrrole-3-carboxamide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-(2-hydroxyethyl)-2,4-dimethyl-](/CAS/20210111/GIF/2170562-55-5.gif) |
1H-Pyrrole-3-carboxamide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-(2-hydroxyethyl)-2,4-dimethyl- |
2170562-55-5 |
C18H18FN3O3 |
![Favipiravir Impurity 14](/CAS/20210111/GIF/356783-49-8.gif) |
Favipiravir Impurity 14 |
356783-49-8 |
C5HClFN3 |
![Posaconazole Impurity 93](/CAS/20200611/GIF/165115-82-2.gif) |
Posaconazole Impurity 93 |
165115-82-2 |
C19H19F2IO2 |
![4-((3-amino-1H-indazol-5-yl)methyl)phthalazin-1(2H)-one](/) |
4-((3-amino-1H-indazol-5-yl)methyl)phthalazin-1(2H)-one |
|
|
![FUROSEMIDE IMPURITY A](/StructureFile/ChemBookStructure22/GIF/CB8587736.gif) |
FUROSEMIDE IMPURITY A |
|
C12H11ClN2O5S |
![GLICLAZIDE IMPURITY F](/) |
GLICLAZIDE IMPURITY F |
|
|
![ONDANSETRON IMPURITY D](/) |
ONDANSETRON IMPURITY D |
|
|
![PERINDOPRIL IMPURITY A](/) |
PERINDOPRIL IMPURITY A |
|
|
![(E)-Ceftiofur](/CAS/20210305/GIF/120882-20-4.gif) |
(E)-Ceftiofur |
120882-20-4 |
C19H17N5O7S3 |
![Cefmetazole Impurity E](/) |
Cefmetazole Impurity E |
|
|
![Cefotiam Impurity 1](/CAS/20210111/GIF/2243596-87-2.gif) |
Cefotiam Impurity 1 |
2243596-87-2 |
C18H23N9O4S3 |
![sodium 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)-1-oxidopiperazin-1-yl)ethoxy)acetate](/) |
sodium 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)-1-oxidopiperazin-1-yl)ethoxy)acetate |
|
|
![1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic acid 3-isopropyl 5-(2-hydroxyethyl) ester](/CAS/GIF/82219-47-4.gif) |
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic acid 3-isopropyl 5-(2-hydroxyethyl) ester |
82219-47-4 |
C20H24N2O7 |
![3-[(3-TRIFLUOROMETHYL)PHENYL]-1-PROPENE](/CAS/GIF/1813-96-3.gif) |
3-[(3-TRIFLUOROMETHYL)PHENYL]-1-PROPENE |
1813-96-3 |
C10H9F3 |
![(AS)-A-(2-CHLOROPHENYL)-2,3,6,7-TETRAHYDRO-2-OXO-THIENO[3,2-C]PYRIDINE-5(4H)-ACETIC ACID METHYL ESTER](/CAS/GIF/527687-26-9.gif) |
(AS)-A-(2-CHLOROPHENYL)-2,3,6,7-TETRAHYDRO-2-OXO-THIENO[3,2-C]PYRIDINE-5(4H)-ACETIC ACID METHYL ESTER |
527687-26-9 |
C16H16ClNO3S |
![2-[2-(2-AMINO-9H-PURIN-9-YL)ETHYL]-1,3-PROPANEDIOL](/CAS/GIF/104227-86-3.gif) |
2-[2-(2-AMINO-9H-PURIN-9-YL)ETHYL]-1,3-PROPANEDIOL |
104227-86-3 |
C10H15N5O2 |
![1,4,8,11-Tetrakis[(4-methylphenyl)sulfonyl]-1,4,8,11-tetraazacyclotetradecane](/CAS2/GIF/71089-74-2.gif) |
1,4,8,11-Tetrakis[(4-methylphenyl)sulfonyl]-1,4,8,11-tetraazacyclotetradecane |
71089-74-2 |
C38H48N4O8S4 |
![3-Cyano-4-isobutoxybenzoic acid](/CAS2/GIF/528607-60-5.gif) |
3-Cyano-4-isobutoxybenzoic acid |
528607-60-5 |
C12H13NO3 |
![REF DUPL: trans-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane](/CAS/GIF/139757-68-9.gif) |
REF DUPL: trans-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane |
139757-68-9 |
C8H11N3O3S |
![1-Propanol,3-[(1,1-dimethylethyl)amino]-2-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]-oxy]-](/CAS2/GIF/59697-06-2.gif) |
1-Propanol,3-[(1,1-dimethylethyl)amino]-2-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]-oxy]- |
59697-06-2 |
C13H24N4O3S |
![rac Cetirizine N-Oxide > 70% by HPLC
(Mixture of Diastereomers)](/CAS/GIF/1076199-80-8.gif) |
rac Cetirizine N-Oxide > 70% by HPLC
(Mixture of Diastereomers) |
1076199-80-8 |
C21H25ClN2O4 |
![(S)-N-Didemethyl Dapoxetine](/CAS/GIF/147199-40-4.gif) |
(S)-N-Didemethyl Dapoxetine |
147199-40-4 |
C19H19NO |
![Hydroxy Flunarizine](/CAS/GIF/87166-81-2.gif) |
Hydroxy Flunarizine |
87166-81-2 |
C26H26F2N2O |
![1-METHYL-4-NITRO-3-PROPYL-1H-PYRAZOLE-5-CARBOXYLIC ACID](/CAS/GIF/139756-00-6.gif) |
1-METHYL-4-NITRO-3-PROPYL-1H-PYRAZOLE-5-CARBOXYLIC ACID |
139756-00-6 |
C8H11N3O4 |
![6-Hydroxy Nicorandil](/CAS/GIF/113743-17-2.gif) |
6-Hydroxy Nicorandil |
113743-17-2 |
C8H9N3O5 |
![trans-Itraconazole](/CAS/GIF/252964-65-1.gif) |
trans-Itraconazole |
252964-65-1 |
C35H38Cl2N8O4 |
![N-(2-Pyridyl)oxamic Acid](/CAS2/GIF/13120-39-3.gif) |
N-(2-Pyridyl)oxamic Acid |
13120-39-3 |
C7H6N2O3 |
![(trans)-4-Propyl-1-methyl-L-proline](/CAS2/GIF/13380-36-4.gif) |
(trans)-4-Propyl-1-methyl-L-proline |
13380-36-4 |
C9H17NO2 |
![N-Nordextromethorphan](/CAS/20211123/GIF/1531-23-3.gif) |
N-Nordextromethorphan
|
1531-23-3 |
C17H23NO |
![(S,S,R,R)-Orlistat](/CAS/GIF/111466-62-7.gif) |
(S,S,R,R)-Orlistat |
111466-62-7 |
C29H53NO5 |
![17β-Carboxy-17-desoxy Dexamethasone](/CAS/GIF/75262-69-0.gif) |
17β-Carboxy-17-desoxy Dexamethasone |
75262-69-0 |
C21H27FO4 |
![1-(dimethoxymethyl)-3-methoxybenzene](/CAS/20180808/GIF/59276-28-7.gif) |
1-(dimethoxymethyl)-3-methoxybenzene |
59276-28-7 |
C10H14O3 |
![Benazepril impurity A](/CAS/20200119/GIF/CB12514371.gif) |
Benazepril impurity A |
|
C24H28N2O5 |
![3S,4R-4-[phenyl-1-methylpiperidinyl] methanol](/CAS/20180906/GIF/176022-03-0.gif) |
3S,4R-4-[phenyl-1-methylpiperidinyl] methanol |
176022-03-0 |
C13H19NO |
![N-[(n-butylaMino)carbonyl]-4-[(3-Methylphenyl)aMino]-3-pyridinesulfonaMide](/CAS/GIF/160972-33-8.gif) |
N-[(n-butylaMino)carbonyl]-4-[(3-Methylphenyl)aMino]-3-pyridinesulfonaMide |
160972-33-8 |
C17H22N4O3S |
![(R)-N-DeMethyl Dapoxetine](/CAS/GIF/1202160-36-8.gif) |
(R)-N-DeMethyl Dapoxetine |
1202160-36-8 |
C20H21NO |
![14,15-Dehydro Budesonide](/CAS/GIF/131918-64-4.gif) |
14,15-Dehydro Budesonide |
131918-64-4 |
C25H32O6 |
![2-(BenzylMethylaMino)-3',4'-dihydroxyacetophenone](/CAS/GIF/36467-25-1.gif) |
2-(BenzylMethylaMino)-3',4'-dihydroxyacetophenone |
36467-25-1 |
C16H17NO3 |
![2'-O-(5'-Deoxy-β-D-ribofuranosyl) Capecitabine](/CAS/GIF/1262133-66-3.gif) |
2'-O-(5'-Deoxy-β-D-ribofuranosyl) Capecitabine |
1262133-66-3 |
C20H30FN3O9 |
![4-Defluoro-4-hydroxy Gefitinib](/CAS/GIF/847949-50-2.gif) |
4-Defluoro-4-hydroxy Gefitinib |
847949-50-2 |
C22H25ClN4O4 |
![Desethyl Sildenafil](/CAS/GIF/139755-91-2.gif) |
Desethyl Sildenafil |
139755-91-2 |
C20H26N6O4S |
![N-Desisopropyl-N-forMyl Bisoprolol](/CAS/20140608/GIF/CB12544017.gif) |
N-Desisopropyl-N-forMyl Bisoprolol |
1346602-59-2 |
C16H25NO5 |
![N-DesMethyl Olopatadine](/CAS/GIF/113835-92-0.gif) |
N-DesMethyl Olopatadine |
113835-92-0 |
C20H21NO3 |
![10-Keto DextroMethorphan](/CAS/20180713/GIF/57969-05-8.gif) |
10-Keto DextroMethorphan |
57969-05-8 |
C18H23NO2 |
![ent-Paroxol](/CAS/GIF/389573-45-9.gif) |
ent-Paroxol |
389573-45-9 |
C13H18FNO |
![Febuxostat Acyl-β-D-glucuronide](/CAS/GIF/1351692-92-6.gif) |
Febuxostat Acyl-β-D-glucuronide |
1351692-92-6 |
C22H24N2O9S |
![Keto Bisoprolol](/CAS/GIF/864544-37-6.gif) |
Keto Bisoprolol |
864544-37-6 |
C18H29NO5 |
![Olopatadine Carbaldehyde DISCONTINUED](/CAS/GIF/1376615-97-2.gif) |
Olopatadine Carbaldehyde DISCONTINUED |
1376615-97-2 |
C21H23NO2 |
![5-Chloro-1-methyl-4-nitroimidazole](/CAS/20200119/GIF/CB12547573.gif) |
5-Chloro-1-methyl-4-nitroimidazole |
|
C4H4ClN3O2 |
![Nisoldipine Related Compound II](/) |
Nisoldipine Related Compound II |
|
|
![5-Chloro-N1-Methylbenzene-1,2-diaMine](/CAS/20150408/GIF/84859-27-8.gif) |
5-Chloro-N1-Methylbenzene-1,2-diaMine |
84859-27-8 |
C7H9ClN2 |
![Brivaracetam Impurity 25](/CAS/20210111/GIF/10547-88-3.gif) |
Brivaracetam Impurity 25 |
10547-88-3 |
C7H12O2 |
![(S)-N-((R)-1-amino-1-oxobutan-2-yl)-3-(bromomethyl)hexanamide](/) |
(S)-N-((R)-1-amino-1-oxobutan-2-yl)-3-(bromomethyl)hexanamide |
|
|
![Peramivir Impurity 19](/) |
Peramivir Impurity 19 |
|
|
![Diquafosol Impurity 13](/CAS/20181212/GIF/211448-81-6.gif) |
Diquafosol Impurity 13 |
211448-81-6 |
C18H28N4O29P6 |
![Montelukast Sodium EP Impurity G](/CAS/20211123/GIF/1428448-96-7.gif) |
Montelukast Sodium EP Impurity G |
1428448-96-7 |
C35H37ClNNaO3S |
![Amifostine related impurities 2](/CAS/20210111/GIF/17002-55-0.gif) |
Amifostine related impurities 2 |
17002-55-0 |
C8H21N3O |
![Oxacillin Impurity F](/CAS/20210111/GIF/5053-35-0.gif) |
Oxacillin Impurity F |
5053-35-0 |
C19H19N3O4S2 |